Last reviewed · How we verify
NCT05671536
The Effect of Motivational Interview on Hemodialysis Patients
NA trial testing motivational interview in Hemodialysis in 58 participants. Status unknown.
30 January 2023
Quick facts
| Lead sponsor | Baskent University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 58 |
| Start date | 26 April 2022 |
| Primary completion | 30 January 2023 |
| Estimated completion | 25 March 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- motivational interview
Conditions studied
- Hemodialysis — all drugs for Hemodialysis →
Sponsor
Baskent University
Who can join
18 and older, any sex, with Hemodialysis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research consists of two stages: the first stage aims to evaluate the validity and reliability of the Hemodialysis Resilience Scale, which was developed to evaluate the resilience of patients receiving hemodialysis treatment, in Turkish society, and the second stage aims to determine the effect of motivational interviewing method on patients' psychological resilience and compliance with hemodialysis treatment in individuals undergoing hemodialysis. The main question it aims to answer is: Does motivational interviewing has an effect on psychological resilience and treatment compliance of hemodialysis patients?
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05671536
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of motivational interview
Trials testing the same drug.
- NCT06345196 — Motivational Interviewing Applied to Individuals With Diabetes · NA · recruiting
- NCT06344663 — Motivational Interviewing Inadequate Milk and Cortisol · recruiting
- NCT05639699 — The Effect of Motivational Interviewing on the Level of Self-Efficacy and Addiction in Smoking Cessation · NA · completed
- NCT06424574 — The Effect of Motivational Interviewing in Children With Type 1 Diabetes · NA · completed
- NCT05676021 — The Effect of Motivational Interviewing on the Adherence to Medication of Patients With COVID-19 Diagnosed at Home · NA · completed
Other recruiting trials for Hemodialysis
Currently open trials in the same condition.
- NCT07278973 — Hemodiafiltration Versus Hemodialysis in Older People · NA · recruiting
- NCT07438925 — Copeptin Concentration Measured in Plasma Samples and Intradialytic Blood Pressure Variation · active not recruiting
- NCT07234890 — Study to Evaluate the Effects of AV-001 on HD-induced Brain Injury. · Phase 2 · recruiting
- NCT07512895 — The Effect of Progressive Muscle Relaxation Exercises on Depression and Fatigue in Patients Receiving Hemodialysis Treat · NA · recruiting
- NCT07076888 — Aerobic Exercises and Hemodialysis Patients · NA · recruiting
Other Baskent University trials
Trials by the same sponsor.
- NCT07521982 — Comparison of Frailty, Physical Fitness Parameters, and Irisin Levels Between Patients With Multiple Sclerosis and Healt · not yet recruiting
- NCT07202650 — THE EFFECT OF GUİDED IMAGERY ON PREMENSTRUAL SYNDROME · NA · recruiting
- NCT07394907 — The Effectiveness of Gamified Metaverse-Based Training on Patient Safety for Nursing Students · NA · not yet recruiting
- NCT07395284 — The Effect of Gamified Metaverse-Based Training on Nursing Students' Self-Efficacy and Metaverse Perception Regarding Pr · NA · not yet recruiting
- NCT07385339 — Comfort Communication Model Intervention for Burn Pain and Pain Anxiety · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05671536 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Baskent University
- Last refreshed: 4 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05671536.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing